PMH71 SOCIODEMOGRAPHIC FACTORS AND TOXIC HABITS RELATED TO STUDENT DRUG USE: THE CASE OF THE TECHNOLOGICAL EDUCATIONAL INSTITUTE OF ATHENS
Carayanni V, Papageorgiou E, Demsia S, Roussou K, Zafiri M TECHNOLOGICAL EDUCATIONAL INSTITUTE OF ATHENS, EGALEO, ATTIKI, Greece OBJECTIVES: The academic area of the Tertiary Education constitutes an important field of adjustment and transaction of the young in the post adolescence age with particular tensions, pressures and stress. The objectives of this study are to focus on the extent of drug use in this student community and the investigation of the relationship between socioeconomic factors, toxic habits and drug use. METHODS: The sampling was selected out of a population of 27,930 students according to stratified sampling weighed by gender, department and semester. The sample size was 829 students, that is sufficient for the estimation of the proportion of users with a significance level of 0.05. The questionnaire comprised 83 items concerning sociodemographic and economic characteristics, adjustment to the academic environment and use of substances. RESULTS: A total of 161 persons, (19.4%) have used drugs at least once. There are significant differences (p 0.01) between users and non users concerning: gender, relations between parents, satisfaction on study, alcohol use, smoking, number of cigarettes/day, friends that are drug users, age of smoke beginners, spending the night. Discriminant analysis has indicated that the discriminant factors between dependents/on a crucial phase, before dependence and non users are: friends that are drug users (0.707), alcohol use (0.627), age of smoke beginners (0.608), relationship between parents (0.392). CONCLUSIONS: It is evident the resulting relationship between illegal and legal psychotropic substances. Consequently, prevention policy should not ignore tobacco and alcohol use. Additionally it is evident the predominant role of the social environment in the use of substances. 
PMH72 BENZODIAZEPINE USE AMONG FREQUENT ATTENDERS TO EMERGENCY DEPARTMENTS: A NATIONWIDE STUDY IN TAIWAN

PMH73 POTENTIAL ABUSE OF COMBINATION ANALGESICS: A DATABASE ANALYSIS
Truter I, Knoesen BC Nelson Mandela Metropolitan University, Port Elizabeth, Eastern Cape, South Africa OBJECTIVES: Medicine abuse is defined as the recurrent use of a medicine in a nonmedical manner for non-medicinal purposes. The potential for abuse of combination (polycomponent) analgesics is high. The primary aim was to detect the potential abuse of combination analgesics using a medicine claims database. METHODS: An analysis of the South African combination analgesic market was made. Thereafter, a retrospective, exposure-cohort drug utilisation study was conducted on a medicine claims database of a medical aid administrator. The medicine file contained 1,357,717 records for 2007. RESULTS: From the analysis of the combination analgesics available, it was found that there were 21 Schedule 5 (prescription-only) tablet formulations (trade names) containing the following identical active ingredients: 320 mg paracetamol, 8 mg codeine phosphate, 32 mg caffeine and 50 mg meprobamate. From the database study, a total of 145,372 analgesics were prescribed (36.82% were available without a prescription). Combination analgesics accounted for 30.21% of all analgesics prescribed (92,181 products at a cost of R2,784,484). Analgesics were often prescribed on an acute basis in excessive quantities, for example 200 tablets. Combination analgesic tablets and capsules were also often dispensed to children in large quantities. For example, 10 prescriptions for 100 tablets of an over-the-counter combination analgesic and eight prescriptions for 100 capsules of a prescription-only combination analgesic, were dispensed to children under seven years, while a syrup (a more suitable dosage form) was available. There was furthermore concern about the quantities of analgesics prescribed to specific families and it was clear that if the medical aid benefit of one family member was exhausted, the analgesic was claimed under another family member's name. A number of prescribers were identified who were over-prescribing specific analgesics. CONCLUSIONS: A medical aid database can be used to detect analgesic abuse and guidelines to control abuse and cost were proposed.
PMH74 REIMBURSEMENT OF INNOVATIVE DRUGS IN SLOVAKIA-PHARMACOECONOMICS OF AGOMELATIN IN DEPRESSION
Tomek D 1 , Psenkova M 2 , Hanzelova M 3 1 Slovak Society for Pharmacoeconomics, Bratislava, Slovak Republic, 2 Pharm-In, Bratislava, Slovak Republic, 3 Servier Slovakia, Bratislava, Slovak Republic OBJECTIVES: Although health spending is well below the OECD average when considered as a share of GDP, Slovakias pharmaceutical expenditures accounts 32% of total health care budget. The accessibility and availability of innovative drugs is good. Mandatory HTA (pharmacoeconomy) is incorporated in all relevant legislation, MoH set the official threshold by l1 a18,000/QALY and l2 a26,500/QALY. METHODS: We have analysed the legislation and official reimbursement decisions and commentaries, published by the MoH in 2009. We analysed the applicants documentation including pharmacoeconomic analysis, as a mandatory part of the application.
RESULTS:
The main drug reimbursement body-Categorisation committee of the MoH-and pharmacoeconomic advisory committee evaluated the applicants dossier for the drug agomelatine (Valdoxan®, Servier Slovakia) for the treatment of depression. The pharmacoeconomic part of the application fulfiled all legislative aspects. The CUA analysis was taken from Swedish pharmacoeconomic model and extrapolated in Slovak environment. CMA in Slovak conditions shows lower drug costs for agomela-
